EDGAR Filing Documents for 0001887703-21-000001

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001887703-21-000001

Filing Date

2021-10-13

Accepted

2021-10-12 18:49:09

Documents

Effectiveness Date

2021-10-13

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	9682
	Complete submission text file	0001887703-21-000001.txt		10689

Mailing Address 777 THIRD AVENUE, SUITE 1704 NEW YORK NY 10017

Business Address 777 THIRD AVENUE, SUITE 1704 NEW YORK NY 10017 212-466-6378

AnBio Therapeutics Ltd. (Filer) CIK: 0001887703 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: D | Act: 33 | File No.: 021-416641 | Film No.: 211319680